Terns Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (TERN)
CUSIP: 880881107
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 115,479,185
- Total 13F shares
- 16,724,968
- Share change
- +103,751
- Total reported value
- $174,276,000
- Price per share
- $10.42
- Number of holders
- 33
- Value change
- +$979,766
- Number of buys
- 19
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 880881107?
CUSIP 880881107 identifies TERN - Terns Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 880881107:
Top shareholders of TERN - Terns Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
3.3%
|
3,791,204
|
$46,480,000 | — | 30 Jun 2021 | |
| FMR LLC |
13F
|
Company |
2.6%
|
3,022,557
|
$37,057,000 | — | 30 Jun 2021 | |
| Vivo Capital, LLC |
13F
|
Company |
2.3%
|
2,675,133
|
$32,797,000 | — | 30 Jun 2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2%
|
2,345,959
|
$28,761,000 | — | 30 Jun 2021 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.97%
|
1,125,136
|
$13,794,000 | — | 30 Jun 2021 | |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.93%
|
1,071,421
|
$13,136,000 | — | 30 Jun 2021 | |
| Antara Capital LP |
13F
|
Company |
0.67%
|
775,934
|
$9,513,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.38%
|
437,604
|
$5,365,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.36%
|
415,730
|
$5,097,000 | — | 30 Jun 2021 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.25%
|
289,068
|
$3,544,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
143,069
|
$1,754,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.11%
|
128,703
|
$1,578,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.08%
|
86,783
|
$1,064,000 | — | 30 Jun 2021 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
0.07%
|
85,000
|
$1,042,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
26,831
|
$329,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.02%
|
23,286
|
$286,000 | — | 30 Jun 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.02%
|
21,359
|
$262,000 | — | 30 Jun 2021 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.02%
|
20,447
|
$251,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
18,200
|
$223,000 | — | 30 Jun 2021 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.02%
|
17,650
|
$216,000 | — | 30 Jun 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.01%
|
14,769
|
$181,000 | — | 30 Jun 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.01%
|
14,237
|
$175,000 | — | 30 Jun 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
12,038
|
$148,000 | — | 30 Jun 2021 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
11,973
|
$147,000 | — | 30 Jun 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
11,419
|
$140,000 | — | 30 Jun 2021 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.01%
|
10,308
|
$126,000 | — | 30 Jun 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
5,894
|
$72,000 | — | 30 Jun 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
5,869
|
$72,000 | — | 30 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
4,975
|
$61,000 | — | 30 Jun 2021 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0%
|
4,883
|
$60,000 | — | 30 Jun 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,180
|
$14,000 | — | 30 Jun 2021 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
879
|
$11,000 | — | 30 Jun 2021 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
708
|
$9,000 | — | 30 Jun 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
596
|
$7,000 | — | 30 Jun 2021 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
415
|
$5,000 | — | 30 Jun 2021 | |
| SIGNATUREFD, LLC |
13F
|
Company |
0%
|
60
|
$1,000 | — | 30 Jun 2021 |
Institutional Holders of Terns Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (TERN) as of Q3 2021
As of 30 Sep 2021,
Terns Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (TERN) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,724,968 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, FMR LLC, Vivo Capital, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), SUVRETTA CAPITAL MANAGEMENT, LLC, MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC, Antara Capital LP, BlackRock Inc., VANGUARD GROUP INC, and Samsara BioCapital, LLC.
This page lists
33
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
36
Q3 2021 holders
33
Holder diff
-3
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.